| Year |
Citation |
Score |
| 2020 |
Proulx J, Joshi C, Vijayaraghavalu S, Saraswathy M, Labhasetwar V, Ghorpade A, Borgmann K. Arginine-Modified Polymers Facilitate Poly (Lactide-Co-Glycolide)-Based Nanoparticle Gene Delivery to Primary Human Astrocytes. International Journal of Nanomedicine. 15: 3639-3647. PMID 32547019 DOI: 10.2147/Ijn.S250865 |
0.473 |
|
| 2019 |
Gao Y, Vijayaraghavalu S, Stees M, Kwon BK, Labhasetwar V. Evaluating accessibility of intravenously administered nanoparticles at the lesion site in rat and pig contusion models of spinal cord injury. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30930216 DOI: 10.1016/J.Jconrel.2019.03.026 |
0.3 |
|
| 2017 |
Joshi CR, Labhasetwar V, Ghorpade A. Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 28160121 DOI: 10.1007/S11481-016-9724-3 |
0.367 |
|
| 2015 |
Petro M, Jaffer H, Yang J, Kabu S, Morris VB, Labhasetwar V. Tissue plasminogen activator followed by antioxidant-loaded nanoparticle delivery promotes activation/mobilization of progenitor cells in infarcted rat brain. Biomaterials. 81: 169-180. PMID 26735970 DOI: 10.1016/J.Biomaterials.2015.12.009 |
0.302 |
|
| 2015 |
Raghavan V, Vijayaraghavalu S, Peetla C, Yamada M, Morisada M, Labhasetwar V. Sustained Epigenetic Drug Delivery Depletes Cholesterol-Sphingomyelin Rafts from Resistant Breast Cancer Cells, Influencing Biophysical Characteristics of Membrane Lipids. Langmuir : the Acs Journal of Surfaces and Colloids. PMID 26439800 DOI: 10.1021/Acs.Langmuir.5B02601 |
0.31 |
|
| 2015 |
Snow-Lisy DC, Sabanegh ES, Samplaski MK, Labhasetwar V. Anatomical Targeting Improves Delivery of Unconjugated Nanoparticles to the Testicle. The Journal of Urology. 194: 1155-61. PMID 25796115 DOI: 10.1016/j.juro.2015.03.076 |
0.301 |
|
| 2015 |
Cramer SA, Adjei IM, Labhasetwar V. Advancements in the delivery of epigenetic drugs. Expert Opinion On Drug Delivery. 12: 1501-12. PMID 25739728 DOI: 10.1517/17425247.2015.1021678 |
0.394 |
|
| 2015 |
Lu S, Morris VB, Labhasetwar V. Codelivery of DNA and siRNA via arginine-rich PEI-based polyplexes. Molecular Pharmaceutics. 12: 621-9. PMID 25591125 DOI: 10.1021/Mp5006883 |
0.346 |
|
| 2015 |
Stees M, Adjei I, Labhasetwar V. A Method for Quantification of Penetration of Nanoparticles through Skin Layers Using Near-Infrared Optical Imaging Cosmetics. 2: 225-235. DOI: 10.3390/Cosmetics2030225 |
0.336 |
|
| 2014 |
Labhasetwar V. 10. Biophysics of cell membrane and nanoparticle interface: Original research article: Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake, 2002. Journal of Controlled Release : Official Journal of the Controlled Release Society. 190: 50-2. PMID 25356480 DOI: 10.1016/J.Jconrel.2014.07.022 |
0.391 |
|
| 2014 |
Peetla C, Jin S, Weimer J, Elegbede A, Labhasetwar V. Biomechanics and thermodynamics of nanoparticle interactions with plasma and endosomal membrane lipids in cellular uptake and endosomal escape. Langmuir : the Acs Journal of Surfaces and Colloids. 30: 7522-32. PMID 24911361 DOI: 10.1021/La5015219 |
0.368 |
|
| 2013 |
Brede C, Labhasetwar V. Applications of nanoparticles in the detection and treatment of kidney diseases. Advances in Chronic Kidney Disease. 20: 454-65. PMID 24206598 DOI: 10.1053/J.Ackd.2013.07.006 |
0.379 |
|
| 2013 |
Singhal A, Morris VB, Labhasetwar V, Ghorpade A. Nanoparticle-mediated catalase delivery protects human neurons from oxidative stress. Cell Death & Disease. 4: e903. PMID 24201802 DOI: 10.1038/Cddis.2013.362 |
0.333 |
|
| 2013 |
Vijayaraghavalu S, Labhasetwar V. Efficacy of decitabine-loaded nanogels in overcoming cancer drug resistance is mediated via sustained DNA methyltransferase 1 (DNMT1) depletion. Cancer Letters. 331: 122-9. PMID 23305699 DOI: 10.1016/J.Canlet.2012.12.009 |
0.343 |
|
| 2013 |
Vijayaraghavalu S, Dermawan JK, Cheriyath V, Labhasetwar V. Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest. Molecular Pharmaceutics. 10: 337-52. PMID 23215027 DOI: 10.1021/Mp3004622 |
0.356 |
|
| 2012 |
Vijayaraghavalu S, Peetla C, Lu S, Labhasetwar V. Epigenetic modulation of the biophysical properties of drug-resistant cell lipids to restore drug transport and endocytic functions. Molecular Pharmaceutics. 9: 2730-42. PMID 22817326 DOI: 10.1021/Mp300281T |
0.362 |
|
| 2012 |
Prabha S, Sharma B, Labhasetwar V. Inhibition of tumor angiogenesis and growth by nanoparticle-mediated p53 gene therapy in mice. Cancer Gene Therapy. 19: 530-7. PMID 22595792 DOI: 10.1038/Cgt.2012.26 |
0.601 |
|
| 2012 |
Snow-Lisy D, Samplaski M, Labhasetwar V, Sabanegh E. FSH ligand targets sertoli cell uptake of nanoparticles Fertility and Sterility. 98: S143. DOI: 10.1016/J.Fertnstert.2012.07.526 |
0.389 |
|
| 2012 |
Snow-Lisy D, Samplaski M, Labhasetwar V, Sabanegh E. Novel technique for nanoparticle delivery to the testis in a rat model Fertility and Sterility. 98: S40. DOI: 10.1016/J.Fertnstert.2012.07.151 |
0.383 |
|
| 2011 |
Snow-Lisy DC, Samplaski MK, Labhasetwar V, Sabanegh ES. Drug delivery to the testis: current status and potential pathways for the development of novel therapeutics. Drug Delivery and Translational Research. 1: 351-60. PMID 25788421 DOI: 10.1007/S13346-011-0039-X |
0.359 |
|
| 2011 |
Sharma B, Ma W, Adjei IM, Panyam J, Dimitrijevic S, Labhasetwar V. Nanoparticle-mediated p53 gene therapy for tumor inhibition. Drug Delivery and Translational Research. 1: 43-52. PMID 22553503 DOI: 10.1007/S13346-010-0008-9 |
0.603 |
|
| 2011 |
Foy SP, Labhasetwar V. Oh the irony: Iron as a cancer cause or cure? Biomaterials. 32: 9155-8. PMID 21963282 DOI: 10.1016/J.Biomaterials.2011.09.047 |
0.313 |
|
| 2011 |
Borgmann K, Rao KS, Labhasetwar V, Ghorpade A. Efficacy of Tat-conjugated ritonavir-loaded nanoparticles in reducing HIV-1 replication in monocyte-derived macrophages and cytocompatibility with macrophages and human neurons. Aids Research and Human Retroviruses. 27: 853-62. PMID 21175357 DOI: 10.1089/Aid.2010.0295 |
0.55 |
|
| 2010 |
Peetla C, Bhave R, Vijayaraghavalu S, Stine A, Kooijman E, Labhasetwar V. Drug resistance in breast cancer cells: biophysical characterization of and doxorubicin interactions with membrane lipids. Molecular Pharmaceutics. 7: 2334-48. PMID 20958074 DOI: 10.1021/Mp100308N |
0.346 |
|
| 2010 |
Yallapu MM, Foy SP, Jain TK, Labhasetwar V. PEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications. Pharmaceutical Research. 27: 2283-95. PMID 20845067 DOI: 10.1007/S11095-010-0260-1 |
0.352 |
|
| 2010 |
Foy SP, Manthe RL, Foy ST, Dimitrijevic S, Krishnamurthy N, Labhasetwar V. Optical imaging and magnetic field targeting of magnetic nanoparticles in tumors. Acs Nano. 4: 5217-24. PMID 20731413 DOI: 10.1021/Nn101427T |
0.354 |
|
| 2010 |
Samplaski M, Smith A, Larchian W, Labhasetwar V, Heston W. 316 SUCCESSFUL INTRAVESICAL THERAPY FOR BLADDER CANCER UTILIZING PACLITAXEL CONTAINING NANOPARTICLES Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.380 |
0.368 |
|
| 2010 |
Vasir JK, Peetla C, Labhasetwar V. Strategies for intracellular delivery of polymer-based nanosystems Rsc Nanoscience and Nanotechnology. 98-113. |
0.744 |
|
| 2009 |
Labhasetwar V, Zborowski M, Abramson AR, Basilion JP. Nanoparticles for imaging, diagnosis, and therapeutics. Molecular Pharmaceutics. 6: 1261-2. PMID 19799461 DOI: 10.1021/Mp9001798 |
0.362 |
|
| 2009 |
Jain TK, Foy SP, Erokwu B, Dimitrijevic S, Flask CA, Labhasetwar V. Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice. Biomaterials. 30: 6748-56. PMID 19765817 DOI: 10.1016/J.Biomaterials.2009.08.042 |
0.37 |
|
| 2009 |
Rao KS, Ghorpade A, Labhasetwar V. Targeting anti-HIV drugs to the CNS. Expert Opinion On Drug Delivery. 6: 771-84. PMID 19566446 DOI: 10.1517/17425240903081705 |
0.586 |
|
| 2009 |
Peetla C, Rao KS, Labhasetwar V. Relevance of biophysical interactions of nanoparticles with a model membrane in predicting cellular uptake: study with TAT peptide-conjugated nanoparticles. Molecular Pharmaceutics. 6: 1311-20. PMID 19243206 DOI: 10.1021/Mp900011H |
0.564 |
|
| 2009 |
Peetla C, Labhasetwar V. Effect of molecular structure of cationic surfactants on biophysical interactions of surfactant-modified nanoparticles with a model membrane and cellular uptake. Langmuir : the Acs Journal of Surfaces and Colloids. 25: 2369-77. PMID 19161268 DOI: 10.1021/La803361Y |
0.363 |
|
| 2009 |
Reddy MK, Labhasetwar V. Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 1384-95. PMID 19124559 DOI: 10.1096/Fj.08-116947 |
0.37 |
|
| 2008 |
Vasir JK, Labhasetwar V. Preparation of biodegradable nanoparticles and their use in transfection. Csh Protocols. 2008: pdb.prot4888. PMID 21356670 DOI: 10.1101/Pdb.Prot4888 |
0.78 |
|
| 2008 |
Reddy MK, Vasir JK, Sahoo SK, Jain TK, Yallapu MM, Labhasetwar V. Inhibition of apoptosis through localized delivery of rapamycin-loaded nanoparticles prevented neointimal hyperplasia and reendothelialized injured artery. Circulation. Cardiovascular Interventions. 1: 209-16. PMID 20031680 DOI: 10.1161/Circinterventions.108.830018 |
0.752 |
|
| 2008 |
Rao KS, Reddy MK, Horning JL, Labhasetwar V. TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs. Biomaterials. 29: 4429-38. PMID 18760470 DOI: 10.1016/J.Biomaterials.2008.08.004 |
0.629 |
|
| 2008 |
Vasir JK, Labhasetwar V. Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles. Biomaterials. 29: 4244-52. PMID 18692238 DOI: 10.1016/J.Biomaterials.2008.07.020 |
0.775 |
|
| 2008 |
Horning JL, Sahoo SK, Vijayaraghavalu S, Dimitrijevic S, Vasir JK, Jain TK, Panda AK, Labhasetwar V. 3-D tumor model for in vitro evaluation of anticancer drugs. Molecular Pharmaceutics. 5: 849-62. PMID 18680382 DOI: 10.1021/Mp800047V |
0.752 |
|
| 2008 |
Jain TK, Richey J, Strand M, Leslie-Pelecky DL, Flask CA, Labhasetwar V. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials. 29: 4012-21. PMID 18649936 DOI: 10.1016/J.Biomaterials.2008.07.004 |
0.387 |
|
| 2008 |
Reddy MK, Wu L, Kou W, Ghorpade A, Labhasetwar V. Superoxide dismutase-loaded PLGA nanoparticles protect cultured human neurons under oxidative stress. Applied Biochemistry and Biotechnology. 151: 565-77. PMID 18509606 DOI: 10.1007/S12010-008-8232-1 |
0.358 |
|
| 2008 |
Peetla C, Labhasetwar V. Biophysical characterization of nanoparticle-endothelial model cell membrane interactions. Molecular Pharmaceutics. 5: 418-29. PMID 18271547 DOI: 10.1021/Mp700140A |
0.37 |
|
| 2008 |
Sahoo SK, Jain TK, Reddy MK, Labhasetwar V. Nano-sized carriers for drug delivery Nanobiotechnology: Bioinspired Devices and Materials of the Future. 329-348. DOI: 10.1007/978-1-59745-218-2_13 |
0.328 |
|
| 2008 |
Yallapu MM, Vasir JK, Jain TK, Vijayaraghavalu S, Labhasetwar V. Synthesis, characterization and antiproliferative activity of rapamycin-loaded poly(N-isopropylacrylamide)-based nanogels in vascular smooth muscle cells Journal of Biomedical Nanotechnology. 4: 16-24. |
0.767 |
|
| 2007 |
Reddy MK, Vasir JK, Hegde GV, Joshi SS, Labhasetwar V. Erythropoietin induces excessive neointima formation: a study in a rat carotid artery model of vascular injury. Journal of Cardiovascular Pharmacology and Therapeutics. 12: 237-47. PMID 17875952 DOI: 10.1177/1074248406297326 |
0.734 |
|
| 2007 |
Vasir JK, Labhasetwar V. Biodegradable nanoparticles for cytosolic delivery of therapeutics. Advanced Drug Delivery Reviews. 59: 718-28. PMID 17683826 DOI: 10.1016/J.Addr.2007.06.003 |
0.793 |
|
| 2007 |
Vijayaraghavalu S, Raghavan D, Labhasetwar V. Nanoparticles for delivery of chemotherapeutic agents to tumors. Current Opinion in Investigational Drugs (London, England : 2000). 8: 477-84. PMID 17621878 |
0.317 |
|
| 2007 |
Braden A, Kashyap A, Vasir J, Labhasetwar V, Vishwanatha JK. Polymeric nanoparticles for sustained down-regulation of annexin A2 lead to reduction in proliferation and migration of prostate cancer cells Journal of Biomedical Nanotechnology. 3: 148-159. DOI: 10.1166/Jbn.2007.010 |
0.349 |
|
| 2007 |
Vasir JK, Labhasetwar V. Controlling Cell Behavior via DNA and RNA Transfections Biomedical Nanostructures. 337-356. DOI: 10.1002/9780470185834.ch13 |
0.716 |
|
| 2006 |
Vasir JK, Labhasetwar V. Polymeric nanoparticles for gene delivery. Expert Opinion On Drug Delivery. 3: 325-44. PMID 16640494 DOI: 10.1517/17425247.3.3.325 |
0.755 |
|
| 2006 |
Rao KS, Labhasetwar V. Trans-Activating Transcriptional Activator (TAT) Peptide-Mediated Brain Drug Delivery Journal of Biomedical Nanotechnology. 2: 173-185. DOI: 10.1166/Jbn.2006.036 |
0.556 |
|
| 2005 |
Sahoo SK, Labhasetwar V. Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Molecular Pharmaceutics. 2: 373-83. PMID 16196490 DOI: 10.1021/Mp050032Z |
0.459 |
|
| 2005 |
Vasir JK, Labhasetwar V. Targeted drug delivery in cancer therapy. Technology in Cancer Research & Treatment. 4: 363-74. PMID 16029056 DOI: 10.1177/153303460500400405 |
0.762 |
|
| 2005 |
Jain TK, Morales MA, Sahoo SK, Leslie-Pelecky DL, Labhasetwar V. Iron oxide nanoparticles for sustained delivery of anticancer agents. Molecular Pharmaceutics. 2: 194-205. PMID 15934780 DOI: 10.1021/Mp0500014 |
0.341 |
|
| 2005 |
Sahoo SK, Panda AK, Labhasetwar V. Characterization of porous PLGA/PLA microparticles as a scaffold for three dimensional growth of breast cancer cells. Biomacromolecules. 6: 1132-9. PMID 15762686 DOI: 10.1021/Bm0492632 |
0.313 |
|
| 2005 |
Vasir J, Reddy M, Labhasetwar V. Nanosystems in Drug Targeting: Opportunities and Challenges Current Nanoscience. 1: 47-64. DOI: 10.2174/1573413052953110 |
0.754 |
|
| 2005 |
Labhasetwar V. What is next for Nanotechnology? Journal of Biomedical Nanotechnology. 1: 373-374. DOI: 10.1166/Jbn.2005.058 |
0.345 |
|
| 2005 |
Davda J, Labhasetwar V. Sustained Proangiogenic Activity of Vascular Endothelial Growth Factor Following Encapsulation in Nanoparticles Journal of Biomedical Nanotechnology. 1: 74-82. DOI: 10.1166/Jbn.2005.010 |
0.341 |
|
| 2005 |
Morales MA, Jain TK, Labhasetwar V, Leslie-Pelecky DL. Magnetic studies of iron oxide nanoparticles coated with oleic acid and Pluronic® block copolymer Journal of Applied Physics. 97. DOI: 10.1063/1.1850855 |
0.317 |
|
| 2004 |
Panyam J, Labhasetwar V. Targeting intracellular targets. Current Drug Delivery. 1: 235-47. PMID 16305387 DOI: 10.2174/1567201043334768 |
0.628 |
|
| 2004 |
Prabha S, Labhasetwar V. Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells. Molecular Pharmaceutics. 1: 211-9. PMID 15981924 DOI: 10.1021/Mp049970+ |
0.654 |
|
| 2004 |
Panyam J, Labhasetwar V. Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles. Molecular Pharmaceutics. 1: 77-84. PMID 15832503 DOI: 10.1021/Mp034002C |
0.699 |
|
| 2004 |
Sahoo SK, Ma W, Labhasetwar V. Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer. International Journal of Cancer. 112: 335-40. PMID 15352049 DOI: 10.1002/Ijc.20405 |
0.425 |
|
| 2004 |
Panyam J, Williams D, Dash A, Leslie-Pelecky D, Labhasetwar V. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles. Journal of Pharmaceutical Sciences. 93: 1804-14. PMID 15176068 DOI: 10.1002/Jps.20094 |
0.672 |
|
| 2004 |
Prabha S, Labhasetwar V. Critical determinants in PLGA/PLA nanoparticle-mediated gene expression. Pharmaceutical Research. 21: 354-64. PMID 15032319 DOI: 10.1023/B:Pham.0000016250.56402.99 |
0.632 |
|
| 2004 |
Satturwar PM, Fulzele SV, Panyam J, Mandaogade PM, Mundhada DR, Gogte BB, Labhasetwar V, Dorle AK. Evaluation of new rosin derivatives for pharmaceutical coating. International Journal of Pharmaceutics. 270: 27-36. PMID 14726119 DOI: 10.1016/J.Ijpharm.2003.10.021 |
0.574 |
|
| 2003 |
Qaddoumi MG, Gukasyan HJ, Davda J, Labhasetwar V, Kim KJ, Lee VH. Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis. Molecular Vision. 9: 559-68. PMID 14566223 |
0.319 |
|
| 2003 |
Panyam J, Dali MM, Sahoo SK, Ma W, Chakravarthi SS, Amidon GL, Levy RJ, Labhasetwar V. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles. Journal of Controlled Release : Official Journal of the Controlled Release Society. 92: 173-87. PMID 14499195 DOI: 10.1016/S0168-3659(03)00328-6 |
0.597 |
|
| 2003 |
Panyam J, Sahoo SK, Prabha S, Bargar T, Labhasetwar V. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles. International Journal of Pharmaceutics. 262: 1-11. PMID 12927382 DOI: 10.1016/S0378-5173(03)00295-3 |
0.743 |
|
| 2003 |
Panyam J, Labhasetwar V. Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharmaceutical Research. 20: 212-20. PMID 12636159 DOI: 10.1023/A:1022219003551 |
0.636 |
|
| 2003 |
Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Advanced Drug Delivery Reviews. 55: 329-47. PMID 12628320 DOI: 10.1016/S0169-409X(02)00228-4 |
0.672 |
|
| 2002 |
Panyam J, Lof J, O'Leary E, Labhasetwar V. Efficiency of Dispatch and Infiltrator cardiac infusion catheters in arterial localization of nanoparticles in a porcine coronary model of restenosis. Journal of Drug Targeting. 10: 515-23. PMID 12575742 DOI: 10.1080/1061186021000038391 |
0.626 |
|
| 2002 |
Prabha S, Zhou WZ, Panyam J, Labhasetwar V. Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. International Journal of Pharmaceutics. 244: 105-15. PMID 12204570 DOI: 10.1016/S0378-5173(02)00315-0 |
0.743 |
|
| 2002 |
Panyam J, Zhou WZ, Prabha S, Sahoo SK, Labhasetwar V. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 16: 1217-26. PMID 12153989 DOI: 10.1096/Fj.02-0088Com |
0.771 |
|
| 2002 |
Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. Journal of Controlled Release : Official Journal of the Controlled Release Society. 82: 105-14. PMID 12106981 DOI: 10.1016/S0168-3659(02)00127-X |
0.727 |
|
| 2002 |
Davda J, Labhasetwar V. Characterization of nanoparticle uptake by endothelial cells. International Journal of Pharmaceutics. 233: 51-9. PMID 11897410 DOI: 10.1016/S0378-5173(01)00923-1 |
0.384 |
|
| 2001 |
Raghuvanshi RJ, Mistra A, Talwar GP, Levy RJ, Labhasetwar V. Enhanced immune response with a combination of alum and biodegradable nanoparticles containing tetanus toxoid. Journal of Microencapsulation. 18: 723-32. PMID 11695637 DOI: 10.1080/02652040110055261 |
0.388 |
|
| 2001 |
Davda J, Labhasetwar V. An update on angiogenesis therapy Critical Reviews in Eukaryotic Gene Expression. 11: 1-21. PMID 11693956 DOI: 10.1615/Critreveukargeneexpr.V11.I1-3.10 |
0.359 |
|
| 2000 |
Zhou WZ, Labhasetwar V. Transfection of Caco-2 cells by PLGA-nanoparticles American Chemical Society, Polymer Preprints, Division of Polymer Chemistry. 41: 1635-1636. |
0.302 |
|
| 1998 |
Labhasetwar V, Song C, Humphrey W, Shebuski R, Levy RJ. Arterial uptake of biodegradable nanoparticles: Effect of surface modifications Journal of Pharmaceutical Sciences. 87: 1229-1234. PMID 9758682 DOI: 10.1021/Js980021F |
0.403 |
|
| 1998 |
Song C, Labhasetwar V, Cui X, Underwood T, Levy RJ. Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: Results with an acute dog model Journal of Controlled Release. 54: 201-211. PMID 9724907 DOI: 10.1016/S0168-3659(98)00016-9 |
0.418 |
|
| 1997 |
Gottsauner-Wolf M, Jang Y, Lincoff AM, Cohen JL, Labhasetwar V, Poptic EJ, Forudi F, Guzman LA, DiCorleto PE, Levy RJ, Topol EJ, Ellis SG. Influence of local delivery of the protein tyrosine kinase receptor inhibitor tyrphostin-47 on smooth-muscle cell proliferation in a rat carotid balloon-injury model American Heart Journal. 133: 329-334. PMID 9060802 DOI: 10.1016/S0002-8703(97)70228-X |
0.326 |
|
| 1997 |
Humphrey WR, Erickson LA, Simmons CA, Northrup JL, Wishka DG, Morris J, Labhasetwar V, Song C, Levy RJ, Shebuski RJ. The effect of intramural delivery of polymeric nanoparticles loaded with the antiproliferative 2-aminochromone U-86983 on neointimal hyperplasia development in balloon-injured porcine coronary arteries Advanced Drug Delivery Reviews. 24: 87-108. DOI: 10.1016/S0169-409X(96)00484-X |
0.379 |
|
| 1997 |
Labhasetwar V, Song C, Levy RJ. Nanoparticle drug delivery system for restenosis Advanced Drug Delivery Reviews. 24: 63-85. DOI: 10.1016/S0169-409X(96)00483-8 |
0.355 |
|
| 1997 |
Song CX, Labhasetwar V, Murphy H, Qu X, Humphrey WR, Shebuski RJ, Levy RJ. Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery Journal of Controlled Release. 43: 197-212. DOI: 10.1016/S0168-3659(96)01484-8 |
0.408 |
|
| 1997 |
Panek R, Chen W, Labhasetwar V, Hamby J, Levy R, Uprichard A, Keiser J. Prolonged vascular effects with drug loaded nanoparticles Proceedings of the Controlled Release Society. 819-820. |
0.342 |
|
| 1996 |
Desai MP, Labhasetwar V, Amidon GL, Levy RJ. Gastrointestinal uptake of biodegradable microparticles: Effect of particle size Pharmaceutical Research. 13: 1838-1845. PMID 8987081 DOI: 10.1023/A:1016085108889 |
0.309 |
|
| 1996 |
Guzman LA, Labhasetwar V, Song C, Jang Y, Lincoff AM, Levy R, Topol EJ. Local intraluminal infusion of biodegradable polymeric nanoparticles: A novel approach for prolonged drug delivery after balloon angioplasty Circulation. 94: 1441-1448. PMID 8823004 DOI: 10.1161/01.Cir.94.6.1441 |
0.361 |
|
| 1995 |
Schwendeman SP, Labhasetwar V, Levy RJ. Model features of a cardiac iontophoretic drug delivery implant Pharmaceutical Research. 12: 790-795. PMID 7479570 DOI: 10.1023/A:1016288315617 |
0.311 |
|
| 1991 |
Labhasetwar V, Levy RJ. Implants for site-specific drug delivery Journal of Applied Biomaterials : An Official Journal of the Society For Biomaterials. 2: 211-212. PMID 10171143 DOI: 10.1002/Jab.770020309 |
0.327 |
|
| 1990 |
Labhasetwar VD, Dorle AK. Nanoparticles - a colloidal drug delivery system for primaquine and metronidazole Journal of Controlled Release. 12: 113-119. DOI: 10.1016/0168-3659(90)90087-A |
0.346 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2013 |
Sharma B, Peetla C, Adjei IM, Labhasetwar V. Selective biophysical interactions of surface modified nanoparticles with cancer cell lipids improve tumor targeting and gene therapy. Cancer Letters. 334: 228-36. PMID 23523612 DOI: 10.1016/J.Canlet.2013.03.011 |
0.3 |
|
| 1994 |
Labhasetwar V, Underwood T, Heil RW, Gallagher M, Langberg J, Levy RJ. Epicardial administration of ibutilide from polyurethane matrices: Effects on defibrillation threshold and electrophysiologic parameters Journal of Cardiovascular Pharmacology. 24: 826-840. PMID 7532762 DOI: 10.1097/00005344-199424050-00019 |
0.298 |
|
| 2013 |
Peetla C, Vijayaraghavalu S, Labhasetwar V. Biophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticles. Advanced Drug Delivery Reviews. 65: 1686-98. PMID 24055719 DOI: 10.1016/j.addr.2013.09.004 |
0.298 |
|
| 1998 |
Labhasetwar V. A DNA controlled-release coating for gene transfer: Transfection in skeletal and cardiac muscle Journal of Pharmaceutical Sciences. 87: 1347-1350. PMID 9811488 DOI: 10.1021/Js980077+ |
0.297 |
|
| 2017 |
Kim MS, Stees M, Karuturi BV, Vijayaraghavalu S, Peterson RE, Madsen GL, Labhasetwar V. Pro-NP™ protect against TiO2 nanoparticle-induced phototoxicity in zebrafish model: exploring potential application for skin care. Drug Delivery and Translational Research. PMID 28299721 DOI: 10.1007/S13346-017-0374-7 |
0.296 |
|
| 2019 |
Lu S, Morris VB, Labhasetwar V. Effectiveness of siRNA Delivery via Arginine-Rich PEI-based Polyplex in Metastatic and Doxorubicin Resistant Breast Cancer Cells. The Journal of Pharmacology and Experimental Therapeutics. PMID 30940690 DOI: 10.1124/jpet.119.256909 |
0.294 |
|
| 1998 |
Labhasetwar V, Strickberger SA, Underwood T, Davis J, Levy RJ. Prevention of acute inducible atrial flutter in dogs by using an ibutilide-polymer-coated pacing electrode Journal of Cardiovascular Pharmacology. 31: 449-455. PMID 9514191 DOI: 10.1097/00005344-199803000-00017 |
0.292 |
|
| 2004 |
Qaddoumi MG, Ueda H, Yang J, Davda J, Labhasetwar V, Lee VH. The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers. Pharmaceutical Research. 21: 641-8. PMID 15139521 DOI: 10.1023/B:Pham.0000022411.47059.76 |
0.292 |
|
| 2011 |
Bhave R, Peetla C, Labhasetwar V. The effect of residual poly(vinylalcohol) on biophysical interaction of nanoparticles with endothelial cell model membrane International Journal of Nanoscience. 10: 539-545. DOI: 10.1142/S0219581X11009349 |
0.292 |
|
| 2008 |
Jain TK, Reddy MK, Morales MA, Leslie-Pelecky DL, Labhasetwar V. Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Molecular Pharmaceutics. 5: 316-27. PMID 18217714 DOI: 10.1021/Mp7001285 |
0.288 |
|
| 2014 |
Adjei IM, Peetla C, Labhasetwar V. Heterogeneity in nanoparticles influences biodistribution and targeting. Nanomedicine (London, England). 9: 267-78. PMID 23799984 DOI: 10.2217/nnm.13.70 |
0.285 |
|
| 2007 |
Yallapu MM, Reddy MK, Labhasetwar V. Nanogels: Chemistry to Drug Delivery Biomedical Applications of Nanotechnology. 131-171. DOI: 10.1002/9780470152928.ch6 |
0.283 |
|
| 1995 |
Labhasetwar V, Levy RJ. Novel Delivery of Antiarrhythmic Agents Clinical Pharmacokinetics. 29: 1-5. PMID 7586894 DOI: 10.2165/00003088-199529010-00001 |
0.279 |
|
| 1995 |
Villa AE, Guzman LA, Poptic EJ, Labhasetwar V, D'Souza S, Farrell CL, Plow EF, Levy RJ, DiCorleto PE, Topol EJ. Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury Circulation Research. 76: 505-513. PMID 7895327 DOI: 10.1161/01.Res.76.4.505 |
0.277 |
|
| 2014 |
Adjei IM, Sharma B, Labhasetwar V. Nanoparticles: cellular uptake and cytotoxicity. Advances in Experimental Medicine and Biology. 811: 73-91. PMID 24683028 DOI: 10.1007/978-94-017-8739-0_5 |
0.276 |
|
| 2019 |
Vijayaraghavalu S, Gao Y, Rahman MT, Rozic R, Sharifi N, Midura RJ, Labhasetwar V. Synergistic combination treatment to break cross talk between cancer cells and bone cells to inhibit progression of bone metastasis. Biomaterials. 227: 119558. PMID 31654872 DOI: 10.1016/J.Biomaterials.2019.119558 |
0.275 |
|
| 1994 |
Schwendeman SP, Amidon GL, Labhasetwar V, Levy RJ. Modulated drug release using iontophoresis through heterogeneous cation- exchange membranes. 2. Influence of cation-exchanger content on membrane resistance and characteristic times Journal of Pharmaceutical Sciences. 83: 1482-1494. PMID 7884674 DOI: 10.1002/Jps.2600831023 |
0.274 |
|
| 2009 |
Smith AK, Larchian WA, Patel AR, Jin S, Chan ESy, Thomas AA, Klein JB, Heston WD, Labhasetwar V. NANOTECHNOLOGY-MEDIATED DELIVERY OF CHEMOTHERAPY IN THE TREATMENT OF UROTHELIAL CARCINOMA Journal of Urology. 181: 408-409. DOI: 10.1016/S0022-5347(09)61161-7 |
0.273 |
|
| 1993 |
Labhasetwar V, Kadish A, Underwood T, Sirinek M, Levy RJ. The efficacy of controlled release D-sotalol-polyurethane epicardial implants for ventricular arrhythmias due to acute ischemia in dogs Journal of Controlled Release. 23: 75-85. DOI: 10.1016/0168-3659(93)90072-D |
0.27 |
|
| 2011 |
Jaffer H, Morris VB, Stewart D, Labhasetwar V. Advances in stroke therapy. Drug Delivery and Translational Research. 1: 409-19. PMID 22201014 DOI: 10.1007/S13346-011-0046-Y |
0.27 |
|
| 1995 |
Levy RJ, Labhasetwar V, Song C, Lerner E, Chen W, Vyavahare N, Qu X. Polymeric drug delivery systems for treatment of cardiovascular calcification, arrhythmias and restenosis Journal of Controlled Release. 36: 137-147. DOI: 10.1016/0168-3659(95)00045-A |
0.258 |
|
| 1997 |
Levy RJ, Labhasetwar V, Underwood T, Song C, Chen W. Arterial nanoparticle administration for restenosis Proceedings of the Controlled Release Society. 189-190. |
0.254 |
|
| 1994 |
Labhasetwar V, Underwood T, Gallagher M, Murphy G, Langberg J, Levy RJ. Sotalol controlled-release systems for arrhythmias: In vitro characterization, in vivo drug disposition, and electrophysiologic effects Journal of Pharmaceutical Sciences. 83: 156-164. PMID 8169781 DOI: 10.1002/Jps.2600830209 |
0.251 |
|
| 2019 |
Andrabi SS, Yang J, Gao Y, Kuang Y, Labhasetwar V. Nanoparticles with antioxidant enzymes protect injured spinal cord from neuronal cell apoptosis by attenuating mitochondrial dysfunction. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 31805339 DOI: 10.1016/J.Jconrel.2019.12.001 |
0.249 |
|
| 2005 |
Labhasetwar V. Nanotechnology for drug and gene therapy: the importance of understanding molecular mechanisms of delivery. Current Opinion in Biotechnology. 16: 674-80. PMID 16263259 DOI: 10.1016/j.copbio.2005.10.009 |
0.248 |
|
| 2003 |
Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discovery Today. 8: 1112-20. PMID 14678737 DOI: 10.1016/S1359-6446(03)02903-9 |
0.245 |
|
| 2014 |
Snow-Lisy DC, Sabanegh ES, Samplaski MK, Morris VB, Labhasetwar V. Superoxide dismutase-loaded biodegradable nanoparticles targeted with a follicle-stimulating hormone peptide protect Sertoli cells from oxidative stress. Fertility and Sterility. 101: 560-7. PMID 24289999 DOI: 10.1016/j.fertnstert.2013.10.034 |
0.243 |
|
| 2009 |
Peetla C, Stine A, Labhasetwar V. Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery. Molecular Pharmaceutics. 6: 1264-76. PMID 19432455 DOI: 10.1021/mp9000662 |
0.242 |
|
| 2018 |
Vijayaraghavalu S, Labhasetwar V. Nanogel-mediated delivery of a cocktail of epigenetic drugs plus doxorubicin overcomes drug resistance in breast cancer cells. Drug Delivery and Translational Research. PMID 29947019 DOI: 10.1007/s13346-018-0556-y |
0.238 |
|
| 2013 |
Jaffer H, Adjei IM, Labhasetwar V. Optical imaging to map blood-brain barrier leakage. Scientific Reports. 3: 3117. PMID 24178124 DOI: 10.1038/Srep03117 |
0.236 |
|
| 1995 |
Labhasetwar V, Underwood T, Schwendeman SP, Levy RJ. Iontophoresis for modulation of cardiac drug delivery in dogs Proceedings of the National Academy of Sciences of the United States of America. 92: 2612-2616. PMID 7708693 DOI: 10.1073/Pnas.92.7.2612 |
0.234 |
|
| 2009 |
Jin S, Labhasetwar V. Nanotechnology in urology. The Urologic Clinics of North America. 36: 179-88, viii. PMID 19406319 DOI: 10.1016/J.Ucl.2009.02.005 |
0.232 |
|
| 2015 |
Kabu S, Jaffer H, Petro M, Dudzinski D, Stewart D, Courtney A, Courtney M, Labhasetwar V. Blast-Associated Shock Waves Result in Increased Brain Vascular Leakage and Elevated ROS Levels in a Rat Model of Traumatic Brain Injury. Plos One. 10: e0127971. PMID 26024446 DOI: 10.1371/Journal.Pone.0127971 |
0.228 |
|
| 2022 |
Ashok A, Andrabi SS, Mansoor S, Kuang Y, Kwon BK, Labhasetwar V. Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation. Antioxidants (Basel, Switzerland). 11. PMID 35204290 DOI: 10.3390/antiox11020408 |
0.226 |
|
| 1995 |
Labhasetwar V, Song C, Humphrey W, Shebuski R, Levy RJ. Nanoparticles for site specific delivery of U-86983 in restenosis in pig coronary arteries Proceedings of the Controlled Release Society. 182-183. |
0.224 |
|
| 2018 |
Joshi CR, Raghavan V, Vijayaraghavalu S, Gao Y, Saraswathy M, Labhasetwar V, Ghorpade A. Reaching for the Stars in the Brain: Polymer-Mediated Gene Delivery to Human Astrocytes. Molecular Therapy. Nucleic Acids. 12: 645-657. PMID 30081235 DOI: 10.1016/j.omtn.2018.06.009 |
0.221 |
|
| 2004 |
Ma W, Yu H, Wang Q, Jin H, Solheim J, Labhasetwar V. A novel approach for cancer immunotherapy: tumor cells with anchored superantigen SEA generate effective antitumor immunity. Journal of Clinical Immunology. 24: 294-301. PMID 15114060 DOI: 10.1023/B:Joci.0000025451.41948.94 |
0.219 |
|
| 1995 |
Song C, Labhasetwar V, Guzman L, Topol E, Levy RJ. Dexamethasone-nanoparticles for intra-arterial localization in restenosis in rats Proceedings of the Controlled Release Society. 444-445. |
0.219 |
|
| 1997 |
Labhasetwar V, Chen B, Muller DWM, Bonadio J, Ciftci K, March K, Levy RJ. Gene-based therapies for restenosis Advanced Drug Delivery Reviews. 24: 109-120. DOI: 10.1016/S0169-409X(96)00485-1 |
0.218 |
|
| 2016 |
Adjei IM, Sharma B, Peetla C, Labhasetwar V. Inhibition of bone loss with surface-modulated, drug-loaded nanoparticles in an intraosseous model of prostate cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 27090164 DOI: 10.1016/J.Jconrel.2016.04.019 |
0.218 |
|
| 2010 |
Manthe RL, Foy SP, Krishnamurthy N, Sharma B, Labhasetwar V. Tumor ablation and nanotechnology. Molecular Pharmaceutics. 7: 1880-98. PMID 20866097 DOI: 10.1021/Mp1001944 |
0.202 |
|
| 2015 |
Morris VB, Labhasetwar V. Arginine-rich polyplexes for gene delivery to neuronal cells. Biomaterials. 60: 151-60. PMID 26000961 DOI: 10.1016/j.biomaterials.2015.04.052 |
0.202 |
|
| 2014 |
Peppas NA, Duncan R, Wnek GE, Hoffman AS, Gao GH, Kim SW, Lee DS, Hadjiargyrou M, Touitou E, Ainbinder D, Mumper R, Rolland A, Niidome T, Labhasetwar V, Liu S, et al. Highly cited research articles in Journal of Controlled Release: Commentaries and perspectives by authors Journal of Controlled Release. 190: 29-74. DOI: 10.1016/S0168-3659(14)00482-9 |
0.2 |
|
| 2007 |
Labhasetwar V, Leslie-Pelecky DL. Biomedical Applications of Nanotechnology Biomedical Applications of Nanotechnology. 1-249. DOI: 10.1002/9780470152928 |
0.199 |
|
| 1996 |
Strickberger SA, Labhasetwar V, Davis J, Underwood T, Levy RJ. Reduced defibrillation thresholds with endocardial administration of artilide Journal of the American College of Cardiology. 27: 265. DOI: 10.1016/S0735-1097(96)81949-8 |
0.198 |
|
| 2005 |
Rao KS, Panda AK, Labhasetwar V. Intravascular drug delivery systems and devices: Interactions at biointerface Surfaces and Interfaces For Biomaterials. 573-584. DOI: 10.1533/9781845690809.4.573 |
0.195 |
|
| 2019 |
Balog BM, Deng K, Labhasetwar V, Jones KJ, Damaser MS. Electrical stimulation for neuroregeneration in urology: a new therapeutic paradigm. Current Opinion in Urology. PMID 30985344 DOI: 10.1097/Mou.0000000000000632 |
0.195 |
|
| 1993 |
Labhasetwar V, Schwendeman SW, Underwood T, Gallagher M, Nguyen T, Langberg J, Levy R. Epicardial iontophoretic delivery of antiarrhythmic agents Proceedings of the Controlled Release Society. 476-477. |
0.19 |
|
| 1996 |
Levy RJ, Song CX, Labhasetwar V, Davis J, Underwood T. The effect of nanoparticle surface modification on arterial retention post angioplasty in a dog femoral artery model Proceedings of the Controlled Release Society. 393-394. |
0.186 |
|
| 1999 |
Labhasetwar V, Bonadio J, Goldstein SA, Levy RJ. Gene transfection using biodegradable nanospheres: Results in tissue culture and a rat osteotomy model Colloids and Surfaces B: Biointerfaces. 16: 281-290. DOI: 10.1016/S0927-7765(99)00079-X |
0.183 |
|
| 2023 |
Rahman MT, Kaung Y, Shannon L, Androjna C, Sharifi N, Labhasetwar V. Nanoparticle-mediated synergistic drug combination for treating bone metastasis. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 37059400 DOI: 10.1016/j.jconrel.2023.04.019 |
0.182 |
|
| 1992 |
Levy RJ, Golomb G, Labhasetwar V. New frontiers in cardiovascular polymeric controlled release Polymeric Materials Science and Engineering, Proceedings of the Acs Division of Polymeric Materials Science and Engineering. 66. |
0.181 |
|
| 1996 |
Strickberger SA, Labhasetwar V, Davis J, Underwood T, Levy RJ. Prevention of atrial flutter with epicardial artilide Journal of the American College of Cardiology. 27: 401. DOI: 10.1016/S0735-1097(96)82537-X |
0.181 |
|
| 1997 |
Song CX, Labhasetwar V, Levy RJ. Controlled release of U-86983 from double-layer biodegradable matrices: Effect of additives on release mechanism and kinetics Journal of Controlled Release. 45: 177-192. DOI: 10.1016/S0168-3659(96)01551-9 |
0.178 |
|
| 1997 |
Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharmaceutical Research. 14: 1568-73. PMID 9434276 DOI: 10.1023/A:1012126301290 |
0.173 |
|
| 2013 |
Lu S, Labhasetwar V. Drug Resistant Breast Cancer Cell Line Displays Cancer Stem Cell Phenotype and Responds Sensitively to Epigenetic Drug SAHA. Drug Delivery and Translational Research. 3: 183-94. PMID 23543868 DOI: 10.1007/s13346-012-0113-z |
0.167 |
|
| 2011 |
Labhasetwar V. Drug resistance in cancer therapy. Drug Delivery and Translational Research. 1: 407-8. PMID 25786361 DOI: 10.1007/s13346-011-0047-x |
0.166 |
|
| 1996 |
Levy RJ, Labhasetwar V, Strickberger SA, Underwood T, Davis J. Controlled release implant dosage forms for cardiac arrhythmias: Review and perspectives Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents. 3: 137-142. |
0.164 |
|
| 2023 |
Toljan K, Ashok A, Labhasetwar V, Hussain MS. Nanotechnology in Stroke: New Trails with Smaller Scales. Biomedicines. 11. PMID 36979759 DOI: 10.3390/biomedicines11030780 |
0.163 |
|
| 1996 |
Labhasetwar V, Underwood T, Davis J, Strickberger SA, Levy RJ. Controlled drug release pacing electrode system for prevention of postoperative atrial flutter Proceedings of the Controlled Release Society. 619-620. |
0.15 |
|
| 2015 |
Kabu S, Gao Y, Kwon BK, Labhasetwar V. Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injury. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26343846 DOI: 10.1016/J.Jconrel.2015.08.060 |
0.141 |
|
| 1989 |
Labhasetwar VD, Puranik PK, Dorle AK. Study of shellac glycerol esters as microencapsulating materials Journal of Microencapsulation. 6: 115-118. PMID 2715911 DOI: 10.3109/02652048909019908 |
0.133 |
|
| 2006 |
Leslie-Pelecky DL, Labhasetwar V, Kraus RH. Nanobiomagnetics Advanced Magnetic Nanostructures. 461-490. DOI: 10.1007/0-387-23316-4_15 |
0.12 |
|
| 2023 |
Jaffer H, Andrabi SS, Petro M, Kuang Y, Steinmetz MP, Labhasetwar V. Catalytic antioxidant nanoparticles mitigate secondary injury progression and promote functional recovery in spinal cord injury model. Journal of Controlled Release : Official Journal of the Controlled Release Society. 364: 109-123. PMID 37866402 DOI: 10.1016/j.jconrel.2023.10.028 |
0.116 |
|
| 2021 |
Liu Y, Hu F, Zhao L, Shakibafard A, Labhasetwar V. Effect of Nano-Platinum on Proliferation and Apoptosis of Non-Small Cell Lung Cancer Cells via P53 Pathway. Journal of Nanoscience and Nanotechnology. 21: 903-908. PMID 33183422 DOI: 10.1166/jnn.2021.18629 |
0.114 |
|
| 1998 |
Labhasetwar V, Chen W, Goldstein S, Bonadio J, Levy R. DNA coating for gene transfer Proceedings of the Controlled Release Society. 372-373. |
0.113 |
|
| 2017 |
Hammiller B, Karuturi BVK, Miller C, Holmes M, Labhasetwar V, Madsen G, Hansen LA. Delivery of antioxidant enzymes for prevention of ultraviolet irradiation-induced epidermal damage. Journal of Dermatological Science. PMID 28793966 DOI: 10.1016/j.jdermsci.2017.07.015 |
0.109 |
|
| 1997 |
Song C, Labhasetwar V, Levy R. Functional PCL/Polyether block copolymers as hemocompatible matrix for protein release Proceedings of the Controlled Release Society. 475-476. |
0.102 |
|
| 1995 |
Labhasetwar V, Mohan MS, Dorle AK. A study on zeta potential and dielectric constant of liposomes Journal of Microencapsulation. 12: 226. DOI: 10.3109/02652049509015293 |
0.098 |
|
| 1994 |
Choudhari KB, Labhasetwar V, Dorle AK. Liposomes as a carrier for oral administration of insulin: Effect of formulation factors Journal of Microencapsulation. 11: 319-325. PMID 8064555 DOI: 10.3109/02652049409040461 |
0.085 |
|
| 2000 |
Desai MP, Hilfinger JM, Amidon GL, Levy RJ, Labhasetwar V. Immune response with biodegradable nanospheres and alum: Studies in rabbits using staphylococcal enterotoxin B-toxoid Journal of Microencapsulation. 17: 215-225. PMID 10738697 DOI: 10.1080/026520400288454 |
0.083 |
|
| 1988 |
Labhasetwar VD, Puranik PK, Dorle AK. Study of shellac-glycerol esters as anhydrous binding agents in tablet formulations Indian Journal of Pharmaceutical Sciences. 50: 343-345. |
0.078 |
|
| 1988 |
Narsimhan R, Labhasetwar VD, Lakhotia CL, Dorle AK. Timed-release noscapine microcapsules Indian Journal of Pharmaceutical Sciences. 50: 120-122. |
0.075 |
|
| 2007 |
Labhasetwar V. A milestone in science: Discovery of the porosome - The universal secretory machinery in cells Journal of Biomedical Nanotechnology. 3. DOI: 10.1166/jbn.2007.023 |
0.072 |
|
| 1993 |
Labhasetwar V, Deshmukh SV, Dorle AK. Studies on some crystalline forms of ibuprofen Drug Development and Industrial Pharmacy. 19: 631-641. DOI: 10.3109/03639049309062971 |
0.07 |
|
| 1996 |
Song CX, Labhasetwar V, Levy RJ. Modulation of release rates from double-layer poly (lactic-co-glycolic acid) films for periadventital implants in restenosis Proceedings of the Controlled Release Society. 473-474. |
0.065 |
|
| 1991 |
Labhasetwar VD, Dorle AK. A study on the zeta potential of microcapsules during ageing Journal of Microencapsulation. 8: 83-85. PMID 1880694 DOI: 10.3109/02652049109021861 |
0.065 |
|
| 1994 |
Labhasetwar V, Dorle AK. Dielectric constant during emulsification Drug Development and Industrial Pharmacy. 20: 2135-2141. DOI: 10.3109/03639049409050226 |
0.059 |
|
| 1990 |
Labhasetwar VD, Puranik PK, Dorle AK. Study of shellac-glycerol esters as microencapsulating materials. II. Quantitative correlation between physico-chemical properties and release characteristics Journal of Microencapsulation. 7: 553-554. PMID 2266478 DOI: 10.3109/02652049009040478 |
0.052 |
|
| 2011 |
Labhasetwar V. Neurodegenerative diseases: challenges. Drug Delivery and Translational Research. 1: 349-50. PMID 25788420 DOI: 10.1007/s13346-011-0040-4 |
0.034 |
|
| 1994 |
Labhasetwar V, Underwood T, Levy RJ. Cardiac iontophoretic implant for antiarrhythmic agents Proceedings of the Controlled Release Society. 97-98. |
0.033 |
|
| 1988 |
Labhasetwar VD, Joshi SV, Dorle AK. A study on the dielectric constant of microcapsules during ageing Journal of Microencapsulation. 5: 339-341. PMID 3236154 DOI: 10.3109/02652048809036731 |
0.027 |
|
| 1988 |
Labhasetwar VD, Dorle AK. A study on the dielectric constant of salicylic acid and aspirin compacts during aging International Journal of Pharmaceutics. 47: 261-262. DOI: 10.1016/0378-5173(88)90239-6 |
0.013 |
|
| 2015 |
Labhasetwar V. The impact of 'negative data'. Drug Delivery and Translational Research. 5: 1-2. PMID 25787334 DOI: 10.1007/s13346-014-0212-0 |
0.01 |
|
| 2011 |
Labhasetwar V, Egashira K, Hanes J. Editorial. Drug Delivery and Translational Research. 1: 1. PMID 25787886 DOI: 10.1007/s13346-010-0013-z |
0.01 |
|
| Hide low-probability matches. |